Skip to main content
Premium Trial:

Request an Annual Quote

... and Bruker Posts 90-Percent Jump in Q1 Profit Despite Slight Revenue Slip

NEW YORK, May 3 (GenomeWeb News) - Bruker BioSciences today posted a slight drop in first quarter revenues even though net income swelled by nearly 90 percent.


For the quarter ended March 31, revenues were $74.4 million, down less than 1 percent from the $74.9 the company earned in the first quarter of 2005.


Bruker said that it spent $10.3 million on R&D in the first quarter, compared to $11 million in the comparable period last year.


Profit in the quarter rose roughly 90 percent to $776,000, from $417,000 in the year-ago period.


As of March 31, Bruker had $96 million in cash and cash equivalents.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.